Shah Smital
Lyell Immunopharma, Inc. · Chief Fin. and Bus. Officer
Shah Smital is listed in public filings as officer: Chief Fin. and Bus. Officer. This Shah Smital insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Lyell Immunopharma, Inc. (LYEL), and Pliant Therapeutics, Inc. (PLRX). Investors use Shah Smital's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $3.6M140k shares | Grant / ExerciseMar 9, 2026 | $3.6M140k shares | $25.50 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $350k26.8k shares | Grant / ExerciseJun 13, 2024 | $349.5K26.8k shares | $13.06 | -- |